ROCHE 0245 ROCHE 0245 (Invirase 200 mg)
Generic Name: saquinavir
Pill imprint ROCHE 0245 ROCHE 0245 has been identified as Invirase 200 mg.
Invirase is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Invirase 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for ROCHE 0245 ROCHE 0245 (Invirase 200 mg)
Invirase
- Generic Name:
- saquinavir
- Imprint:
-
ROCHE 0245
ROCHE 0245 - Strength:
- 200 mg
- Color:
- Green / Yellow
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0245
- Inactive Ingredients:
- lactose
microcrystalline cellulose
povidone k30
sodium starch glycolate type A potato
magnesium silicate
magnesium stearate
gelatin
water
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
FD&C Blue No. 2
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-3699 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More resources
Invirase is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
